Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Table of Contents What Is Retatrutide and Its Role in Weight Loss Treatment Understanding Retatrutide Reconstitution: Important Safety Information Reconstitution Calculators: Why They Are Not Appropriate for Patient Use Dosing Considerations and MHRA Safety Guidance Risks of Incorrect Reconstitution and When to Seek Advice Accessing Weight Loss Medicines Safely Through UK Healthcare Scientific References Frequently Asked Questions What Is Retatrutide and Its Role in Weight Loss Treatment Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) not yet licensed by the MHRA or EMA, meaning it cannot legally be prescribed or supplied as a medicine in the UK outside approved clinical trials
One of the primary benefits is its impact on energy levels
For example, adding 10 mL creates a less concentrated solution than adding 5 mL
4 wks @ 250 mcg/day: ~1 vial (20 mg) 4 wks @ 500 mcg/day: ~1 vial (20 mg), leftover On 10 mg vials: roughly double the vial count Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 4 weeks (once daily): ~28 syringes 8 weeks (once daily): ~56 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per blend vial for reconstitution
